Literature DB >> 21874226

Novel GATA4 mutations in lone atrial fibrillation.

Jin-Qi Jiang1, Fang-Fang Shen, Wei-Yi Fang, Xu Liu, Yi-Qing Yang.   

Abstract

Atrial fibrillation (AF) is the most frequent cardiac arrhythmia and is a major cause of morbidity and mortality. Previous studies have established genetic defects as a risk factor for AF in a minority of patients. However, AF is of substantial genetic heterogeneity and the molecular determinants for AF in a majority of cases remain unclear. In this study, the entire coding sequence and splice junctions of GATA4, which encodes a zinc-finger transcription factor essential for cardiogenesis, were sequenced in 160 unrelated patients with lone AF. A total of 200 unrelated ethnically matched healthy individuals were used as controls. The available relatives of the patient carrying an identified mutation were genotyped. The functional characteristics of the mutant GATA4 were analyzed using a luciferase reporter assay system. As a result, two novel heterozygous GATA4 mutations of p.G16C and p.H28D, were identified in 2 unrelated families with AF, respectively, which co-segregated with AF in each family with complete penetrance. Functional analysis demonstrated that the mutations of GATA4 were associated with a significantly decreased transcriptional activity. The findings expand the mutation spectrum of GATA4 linked to AF and provide novel insight into the molecular mechanism involved in the pathogenesis of AF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874226     DOI: 10.3892/ijmm.2011.783

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

Review 1.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

3.  Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot.

Authors:  Juan Wang; Xue-Jiao Luo; Yuan-Feng Xin; Yi Liu; Zhong-Min Liu; Qian Wang; Ruo-Gu Li; Wei-Yi Fang; Xiao-Zhou Wang; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2012-09-28       Impact factor: 3.311

4.  Atrial fibrillation risk loci interact to modulate Ca2+-dependent atrial rhythm homeostasis.

Authors:  Brigitte Laforest; Wenli Dai; Leonid Tyan; Sonja Lazarevic; Kaitlyn M Shen; Margaret Gadek; Michael T Broman; Christopher R Weber; Ivan P Moskowitz
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 5.  Atrial fibrillation: the role of common and rare genetic variants.

Authors:  Morten S Olesen; Morten W Nielsen; Stig Haunsø; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

6.  Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation.

Authors:  Jun Wang; Yu-Min Sun; Yi-Qing Yang
Journal:  Mol Biol Rep       Date:  2012-05-03       Impact factor: 2.316

Review 7.  Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future?

Authors:  William J Hucker; Harsimran Saini; Steven A Lubitz; Patrick T Ellinor
Journal:  Can J Cardiol       Date:  2016-02-12       Impact factor: 5.223

8.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

9.  Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation.

Authors:  Jian-Yun Gu; Jia-Hong Xu; Hong Yu; Yi-Qing Yang
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

10.  GATA5 loss-of-function mutations underlie tetralogy of fallot.

Authors:  Dong Wei; Han Bao; Xing-Yuan Liu; Ning Zhou; Qian Wang; Ruo-Gu Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.